Stem Cell Therapeutics Advances CD47 Antagonist Program into Ind-Enabling Phase

News   Sep 09, 2013

 
Stem Cell Therapeutics Advances CD47 Antagonist Program into Ind-Enabling Phase
 
 
 

RELATED ARTICLES

Brian Berridge Set to Manage National Toxicology Program

News

The National Toxicology Program (NTP) has named Brian Berridge, D.V.M., Ph.D., as its new Associate Director. Berridge, formerly of GlaxoSmithKline, will oversee day-to-day operations as NTP coordinates toxicology research and testing across nine different federal agencies.

READ MORE

Heart-muscle Patches Created from Human Cells Improve Recovery from Heart Attacks

News

Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery from heart attack injury.

READ MORE

Arsenic-Tainted Drinking Water May Increase Diabetes Risk

News

A new study reports that chronic exposure to arsenic interferes with insulin secretion in the pancreas, which may increase the risk of diabetes.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE